Clinical Trials Logo

Metastatic Merkel Cell Carcinoma clinical trials

View clinical trials related to Metastatic Merkel Cell Carcinoma.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT03089658 Approved for marketing - Clinical trials for Metastatic Merkel Cell Carcinoma

Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)

Start date: n/a
Phase:
Study type: Expanded Access

Expanded access to Avelumab solution for infusion will be made available for adult patients with mMCC whose disease has progressed after receiving at least one prior chemotherapy.